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Abstract: Samples of blood, kidney and liver were randomly selected from slaughtered 
pigs (n=90) and analyzed for ochratoxin A by HPLC. In addition, in order to obtain 
information on the occurrence of nephropathy, histological examinations were carried 
out. Of the 90 liver samples, 26.6% contained OTA in the range of 0.22-14.5 ng/g. The 
incidence of OTA in serum and kidney were very similar (31%, 33.3%), with a maximum 
concentration of 220.8 ng/mL, and 52.5 ng/g, respectively. Histopathological 
examination of kidneys confirmed tubulopathies with edema and cell vacuolization. In 
addition, hemorrhages and necrosis of proximal kidney tubules’ cells were found.   
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1. Introduction 
 
Ochratoxin A (OTA) is a nephrotoxic mycotoxin produced by several species in the Aspergillus and 
Penicillium genera. These species occur worldwide, as a contaminant of agricultural commodities, 
especially cereals [1], but also in a variety of other food commodities [2, 3] as a result of poor storage 
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of said commodities or poor agricultural practice during drying procedures [4]. OTA is nephrotoxic to 
all animal species and causes mycotoxicosis in animals, particularly in swine [5, 6] and this mycotoxin 
plays a special role in the genesis of mycotoxic porcine nephropathy (MPN), a common disease in 
Scandinavia [5]. OTA has been considered as possible cause of the human disease known as Balkan 
Endemic Nephropathy (BEN) [7]. The toxicological profile of OTA includes teratogenesis, 
nephrotoxicity and immunotoxicity [8]. Moreover, OTA was classified as being carcinogenic in 
animals [9-11]. Special attention has been paid to OTA since 1993, when the International Agency for 
Research on Cancer classified this toxin as a possible human carcinogen (group 2B) [12-14]. Under 
certain circumstances the levels of OTA in pig blood are of great concern. Hult et al. (1980) 
demonstrated that the level of OTA in blood is very expressive of the general exposure of the 
individuals to this mycotoxin and would be a useful tool in diagnosing ochratoxicosis. The high 
affinity of OTA to proteins, particularly to serum albumin, allows its accumulation in the organs of 
animals [16]. In fact, animal-derived products and tissues for human consumption may well present 
OTA residues even if the animal has been nourished with feeds contaminated with low levels of OTA. 
In many studies, OTA has been detected in pig’s blood, kidney, liver muscle and adipose tissue with 
rather high levels found in animals suffering from porcine nephropathy [6, 17-22], especially in 
countries of Balkan Peninsula [23-27]. A nephropathy in pigs with characteristic macroscopic changes 
of the type “mottled or pale enlarged kidneys” has been frequently identified at meat inspection in 
Serbia, corresponding well with the data found in other countries of the Balkan Peninsula [24].   
The purpose of this work was to monitor the presence of OTA in edible tissues of normally 
slaughtered Serbian swine, and also to evaluate data for the relation between the content of ochratoxin 
A and pathomorphological changes in kidney.   
 
2. Results and Discussion     
 
2.1. Occurrence, concentration and regional distribution of Ochratoxin A in tissues 
 
The occurrence and mean concentrations of ochratoxin A in swine serum, kidney and liver are 
summarized in Tables 1 and 2. 
 
2.1.1. Ochratoxin A in Serum     
 
OTA contamination assessment showed that 28 (31%) of the analyzed serum samples (n = 90) were 
contaminated in a very wide range from 0.22 to 220.8 ng/mL (mean levels 3.70 ± 23.59 ng/mL). The 
incidences of OTA and mean level of contamination in the three regions where samples were collected 
are very different (Table 1), varying between 16.6% (mean-0.19 ng/g, Vladimirci) to 43.3% (mean-
2.33 ng/g, Senta). The highest OTA level 220.8 ng/mL (mean-8.58 ng/mL), with the highest 
coefficient of variation (4.69) was found in the samples originate from the Bogatić region. Analysing 
the range of OTA levels in fourteen samples (15.5%), levels of ochratoxin A ranged from 0.1 to 1 
ng/mL. The concentrations in a further eight samples (8.8%) fell between 1-5 ng/mL while the rest of 
the samples (6.6%) had concentrations greater than 5 ng/mL. The incidences of higher concentrations Int. J. Mol. Sci. 2008, 9          
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of ochratoxin A (> 5 ng/mL) in serum was similar to those in kidney (6.6 and 5.5% respectively), 
while ochratoxin A was greater than 5 ng/g in only two (2.2%) liver samples (Table 2).   
 
Table 1. Incidence of ochratoxin A in tissues of slaughtered pigs. 
Region N 
Serum (ng/mL) 
n (%)  X ±Sd C.V.  Range 
Vladimirci 30  5  (16.5)  0.1±90.57 2.96  0.33-2.56 
Senta 30  13  (43.3)  2.33±6.91 2.96  0.24-35.7 
Bogatić 30  10  (33.3)  8.58±40.25 4.69 0.22-221 
Total 90  28  (31.1)  3.70±23.6 6.37  0.22-221 
     Kidneys (ng/g)   
Vladimirci 30  8  (26.6)  0.42±1.2 2.96  0.18-6.5 
Senta 30  11  (36.6)  1.14±3.3 2.89  0.17-17 
Bogatić 30  11  (36.6)  2.2±9.54 4.33  0.26-52.5 
Total 90  30  (33.3)  1.26±5.85 4.64  0.17-52.5 
     Liver (ng/g)   
Vladimirci 30 11  (36.6) 0.48±0.75 1.55 0.32-2.2 
Senta 30  4  (13.3)  0.84±2.95 3.51  0.56-14.5 
Bogatić 30  9  (30)  0.56±1.17 2.09  0.22-5.46 
Total 90  24  (26.6)  0.63±1.87 2.96  0.22-14.5 
N-total number of analyzed samples, n-number of positive 
samples,  X -arithmetic mean (conc. below LOD are regarded 
as zero), C.V.-coeff. of variation. 
 
2.1.2. Ochratoxin A in Kidney 
 
In contrast, our results showed that the frequency of contamination of OTA was higher in the 
kidney than in the serum and liver (Table 1). The incidence of ochratoxin A among the three regions 
where samples were collected varied between 26.6% (Vladimirci) to 36.6% (Senta and Bogatić) with a 
mean contamination frequency of 33.3%. In regard to regional distribution of OTA, the average OTA 
concentration in positive samples varied between 0.42 ng/g (Vladimirci) and 2.2 ng/g (Bogatić) where 
there is the highest concentration of OTA 52.5 ng/g. The majority of samples (16.6%) contained OTA 
at low levels (0.01-1 ng/g). The concentrations in a ten samples (11.1%) ranged between 1-5 ng/g, 
while ochratoxin A in five (5.5%) samples was greater than 5 ng/g (Table 2). In 2.2% samples of Int. J. Mol. Sci. 2008, 9          
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kidneys, OTA levels was considerably higher and greatly exceed the permissible levels of this toxins 
established in Serbia and included those proposed (10 ng/g) by the SCF [33], and JECFA [34].   
 
Table 2. Distribution of ochratoxin A in tissues of slaughtered pigs in the regions where 
samples were collected. 
N-total number of analyzed samples, nd-not detectable, 
bLOD -limit of 
detection (see Experimental Section). 
 
2.1.3. Ochratoxin A in Liver 
 
In the present study, OTA was detected in 24 (26.6%) out of 90 liver samples with a much lower 
mean value (0.63 ng/g) than in kidney (1.26 ng/g) (Table 1). The majority of samples (15.5%) 
contained OTA between 1-5 ng/g, while ochratoxin A in only two (2.2%) samples of liver was greater 
than 5 ng/g (Table 2). In regard to the regional distribution of OTA, the occurrence of OTA among the 
regions where samples were collected are different and varied between 13.3% (Senta) to 36.6% 
(Vladimirci), but the mean level of contamination were very similar (0.48-0.84 ng/g). The highest 
        Number of samples in the range 
      Serum 
Region  N   < LOD  0.1
b-1 1-5  >5 
Vladimirci 30 25  3  2  0 
Senta 30  17 6  4  3 
Bogatić 30  20  5  2  3 
Total 90  62 14 8  6 
   Kidneys 
   <  LOD  0.01
b -1  1-5  >5 
Vladimirci 30 22  5  2  1 
Senta 30  19 5  4  2 
Bogatić 30  19  5  4  1 
Total 90  60 15 10  5 
   Liver 
   <  LOD  0.01
b -1  1-5  >5 
Vladimirci 30 19  5  6  0 
Senta 30  26 1  2  1 
Bogatić 30  21  2  6  1 
Total 90  66 8 14  2 Int. J. Mol. Sci. 2008, 9          
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OTA level 14.5 ng/g (mean OTA 0.84 ng/g), with the highest coefficient of variation (3.51) was found 
in the samples from Senta.   
Comparison with other published data for the occurrence of OTA and contamination level was 
generally not different from other European countries such as Sweden, Poland, and Germany, or in 
areas of Balkan Peninsula and Canada (Table 3). 
The present work indicates that regional variations and seasonal differences were observed. 
Geographical origin and season were recognized as the main factor influencing the OTA content of 
tissues when samples of the three different regions were compared. During period December-February 
the mean content of OTA in serum samples in the investigated regions was significantly different (p < 
0.05), while the mean content of OTA in liver samples was highly significantly different (p < 0.01). 
The regional differences and seasonal variations might thus partially explain the concentration 
differences in the corresponding formulas, as could differences in the storage condition of feedstuffs. 
In addition, fluctuations in mould growth and contamination level of cereals may result in seasonal 
variations in dietary exposure to OTA. The highest mean level of OTA found in Bogatić region, could 
signal a possible relationship between this region and the Balkan Endemic Nephropathy. 
 
Table 3.  Incidence of ochratoxin A in tissues of slaughtered pigs in 
different countries. 
Samples Country 
Incidence
% 
Mean 
ppb 
Range 
ppb
References 
Serum 
Sweden 18 
6.7   [28] 
9.4   [29] 
Poland 38     [30] 
Germany 48.7  5.8    [3] 
France  2    up to 6  [40] 
Romania  98  2.43  up to 13.4 [25] 
Bulgaria 100  60.9   [24] 
Canada 36  14   [32] 
Serbia 56.6  2.91  2.5-33  [26]   
Kidney 
Germany 41.9  0.43    [41] 
Serbia 41.6  3.12    [27] 
Liver 
Germany 17  0.07   [22] 
Romania 75  0.16   [25] 
Serbia  46.6  2.88  up to 19.5 [27]   
 
With regards to a consumer safety point of view, the literature contains several studies investigating 
the ration between the levels of OTA in pig kidneys and pig meat [20, 25, 35, 36, 39]. A contamination 
level for the entire carcass at 25 ng/g pig kidney should secure that the level in meat do not exceed 10 
ng/g, based on the estimation that the OTA level in pig meat is approximately 40% of the level in pig Int. J. Mol. Sci. 2008, 9          
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kidney. The ration “content in meat/content in kidney” varied between 10 and 90%, and can depend on 
many factors, e.g. the content of OTA in feed, feeding period, feeding in relation to time of 
slaughtering. The results from these survey indicated that there was a low correlation between the 
OTA level in serum and liver as well as in the OTA level in kidney and liver (r = 0.319 and r = 0.341, 
respectively) while the strongest correlation was found between the OTA level in serum and in kidney 
(r = 0.973). A similar correlation was found by [39]. The effects of OTA appeared to be longer-lasting 
than those of other mycotoxins, and possessed cumulative feature. Comparison the data obtained in 
this trial with other recently published data for the occurrence of OTA in pig edible tissues shows that 
the found levels are comparable with levels in other European countries [24, 39, 40]. However, it 
should be remembered when comparing data that factors such as climate conditions during harvest, 
practices for grain/feed storage etc have influence on the ochratoxin A level in edible tissues. The data 
obtained in this trial show it should be raises some concern for the livestock industry. 
 
2.2. Pathomorphology examination 
 
2.2.1. Gross pathology 
 
In all 90 pigs were slaughtered during the study period. Kidneys which were submitted to the 
laboratory were pale, swollen and enlarged and change in color from the normal mahagony to tan, as 
follows: 43 (47.7%) had “mottled or pale kidneys”, while 27 (30%) were enlarged (Figure 1) and 11 
(12.2%) was smaller than normal. The only other macroscopic lesion in few cases was a small grey-
white foci on the kidney surface. No obvious difference was observed between the right and left 
kidney. No significance changes were seen in other organs.   
 
Figure 1. External surface of a case of “mottled enlarged kidneys” (A) (second and fifth 
kidney dorsal aspect), and (B) normal sized kidneys, except for the third. 
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2.2.2. Histological examination 
 
Histological examination showed two types of changes: degenerative – affecting epithelial cells in 
some proximal tubules of pigs, and proliferative changes in the interstitium (Figure 2). The major renal 
histopathological changes were mainly in the epithelium of proximal tubules. Dystrophy (moderate to 
marked degenerative changes, Figure 3A), swelling, vacuolization and fatty changes, were the main 
changes in the tubular epithelial cells. The majority of glomeruli exhibited mild or moderate exudates 
in Bowman’s capsular spaces as well as hypercellularity of vascular loops. In addition vascular 
changes expresed as a hyperaemia of blood vessels, moderate to marked hemorrhages of some renal 
cortical regions occurred occasionally (Figure 3D). In the interstitium of some renal cortical regions, 
there was limited proliferation of connective tissue (Figure 3B) and focal infiltration of mononuclear 
inflammatory cells which was sometimes accompanied by small granuloms. These results have also 
been reported in other papers [24, 42-46].   
 
Figure 2. Summary of histological findings (PH) of renal tissues and incidence of OTA in 
kidney from slaughtered pigs (n=90). Necrosis of proximal tubules’ cells (1), 
hypercellularity of vascular loop (2), vascular changes (3), exudat in Bowman’s space (4), 
focal interstitial nephritis (5), dystrophy of proximal tubules’ cells (6), swelling of 
proximal tubules’ cells (7), renal hemorrhages (8), fatty changes of proximal tubules’  
cells (9). 
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OTA analysis of the kidneys samples where degenerative changes of moderate to marked cloudy 
swelling were seen revealed the incidence of OTA in 32.2% samples at concentrations levels up to 
52.5 ng/g (Figure 2). Additionally, vascular changes as well as fatty changes were observed in six 
kidneys of pigs were ochratoxin A detected up to 6.5 ng/g, while focal interstitial fibrosis and necrosis 
of  proximal tubules’ cells were only seen in one kidneys of pigs were ochratoxin A detected up to 
52.5 ng/g. In comparison, the lesions produced by higher OTA levels were more severe and 
widespread, including degeneration, atrophy, glomerular swelling and sclerosis and interstitial 
nephritis (Figure 2). Int. J. Mol. Sci. 2008, 9          
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Figure 3. Dystrophy and vacuolar degeneration in the epithelium of proximal tubules’ cells 
(A), focal interstitial fibrosis (B), necrosis of proximal tubules’ cells (C) and hemorrhages 
in cortex (D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The kidney is the main target of OTA, although it has been shown that possible targets of OTA are 
the liver, the immune system, and brain cells [47–49]. This high susceptibility of the kidney is, at least 
in part, the result of OTA-toxicokinetics. Renal blood flow per tissue weight is extremely high, 
resulting in the delivery of relative large amounts of OTA as compared to other organs. Furthermore, 
free OTA is secreted in the proximal tubule and subsequently reabsorbed, mainly in the proximal 
straight tubule, the thick ascending limb of the loop of Henle and the collecting duct [50-56]. 
Mechanisms involved in reabsorption are, e.g., H+-dipeptide-cotransporter(s) and non-ionic diffusion 
[52, 55, 56]. These toxicokinetic features result in an accumulation of OTA in renal tissue, where the 
highest concentrations have been detected in the papilla and the inner medulla [57]. The inhibition of 
protein synthesis and the damaged energy production in the mitochondria could be considered as the 
most important factors for degenerative changes in the epithelial cells of proximal tubules where 
ochratoxin A was detected [58]. While agreeing that the most important toxicological target of OTA in 
the pig is the kidney, the principal descriptions of the pathology of MPN vary considerably with 
respect to some other details, and according to the dosing regime and the duration of OTA exposure. 
Enlarged kidneys are indicative of renal inflammation and proliferative lesions following chronic 
exposure to OTA [24, 46]. In the present study no association was found between OTA contamination 
and kidney weight. Twelve (28%) out of 43 “mottled or pale kidneys” samples were found to contain 
OTA, whereas that in the enlarged kidney was 44.4% in the range 0.17-52.5 ng/g. However, the 
average concentrations of OTA in some feeds for pigs in Serbia (up to 0.25 mg/kg) were substantially 
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lower than the 1–2 ppm required to reproduce the classical MPN reported in Denmark. Also, pigs may 
well contain ochratoxin A in high amounts without any macroscopic chances of the kidneys, as it may 
take several weeks on ochratoxin A contaminated feeding before porcine nephropathy develops. 
Many studies on the role of environmental and host factors have been carried out to elucidate the 
aetiology of both diseases (BEN and MPN). Such factors include heavy metals [59-62] and other 
minerals [63], bacteria, leptospira, viruses [64, 65], fungal toxins and, recently, Pliocene lignite’s [66], 
but much stronger evidence support the hypothesis that BEN and MPN have mycotoxic aetiology. It 
seems, therefore, that MPN observed in Serbia may have a multitoxic aetiology, because it cannot be 
explained by the concentration of OTA alone. The lack of a strong correlation among histopathological 
changes and incidence of OTA in kidney (33.3% kidneys samples were positive, at levels ranging up 
to 52.5 ng/g) found in our trial might thus explain the result of OTA-toxicokinetics as well as possible 
synergism between OTA and other nephrotoxic mycotoxins or compounds which enhance the toxicity 
of OTA. Such synergism between OTA and other mycotoxins under field conditions may be 
responsible for the MPN in Serbia, associated with relatively low mean contamination by OTA in feed. 
The production of multiple toxins by one or several fungi [67], as is sometimes the natural situation, 
presents a problem that has not been sufficiently investigated. Considering the similarities with the 
frequency and levels of OTA reported in other countries, it seems that OTA in Serbian slaughtered 
pigs represent a particular situation.   
The timely diagnosis of disease during the meat inspection at slaughterhouses is very important. 
The Serbian control system for content of OTA in pig kidney is not yet established, and can be 
regarded as a lack from a consumer safety point of view. However, the actual concentration in pork is 
generally very low and hence for the consumer the contribution to the total intake of ochratoxin A 
from pig products is very small compared with other sources [68]. The values are far below the 
Acceptable Daily Intake (ADI) of these toxins [33, 34], but high amounts of very hazardous and 
relatively heat stable OTA may enter in the food chain without any control system. With the present 
safety evaluation of ochratoxin A [33, 34], a residue limit of 10 ng/g in pork would not be considered 
satisfactory from a consumer safety point of view. 
The prevalence of mycotoxin-induced nephropathy is still unknown, and epidemiological studies 
must be carried out on a large scale in livestock population where ochratoxin A levels in feed are high, 
as they are also relevant for the understanding of human nephropathies.   
 
3. Experimental Section   
 
3.1. Reagents 
 
OTA (benzene free) were purchased from Sigma-Aldrich Chemie GmbH. Stock concentrated 
solution was prepared in toluene-acetic acid (99:1 v/v) at final concentration of 1 mg/mL and stored at 
-20 °C, protected from light. The OTA working solution was prepared by diluting the stock solution 
with toluene-acetic-acid (99:1 v/v) to ∼10μg/mL. The actual concentration of OTA was calculated 
using UV spectrophotometer set at 333 nm (ε 5,550). After suitable dilutions in water-methanol-acetic 
acid (50:49:1 v/v/v), the working solution was used to prepare the external calibration curve. A Int. J. Mol. Sci. 2008, 9          
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working standard OTA for HPLC was prepared daily just before starting the injection of a series of 
samples. Other reagents were HPLC grade. All other chemicals were reagent grade or chemically pure. 
 
3.2. Sample collection 
 
During six month period (September 2006/February 2007), samples of blood, kidney and liver from 
each animal were collected from healthy slaughtered pigs (n = 90) originating from three different 
regions of Serbia where there is a significant swine industry. Slaughtered pigs were randomly sampled 
in the slaughterhouse during meat inspection. Serum samples were collected from each studied farm 
and liver and kidneys of corresponding animals. About 50 mL blood/pig was sampled when 
slaughtered pigs were bled by jugular puncture. Blood samples remained at room temperature for 24 h 
to allow clotting to occur, and were then centrifuged at 3,000 × g for 20 min. Serum was decanted and 
stored at -20 °C prior to analysis. About 100 g of liver and whole kidney were sampled from each pig. 
After cutting pieces of kidney for histological examination, the rest of sample was homogenized and 
stored at -20 °C before analysis. No preservatives were added. For microscopic examination kidney 
samples were fixed in 10% neutral buffered formalin. and absolute alcohol for 5 to 7 days, processed 
by routine methods, sectioned at 5-8 μm, and stained with haematoxylin and eosin (HE) for light 
microscopy. 
 
3.3. Extraction and clean-up for ochratoxin analyses 
 
3.3.1. Extraction and clean-up for ochratoxin analyses from serum 
 
Serum (0.8 mL) was extracted according to Curtui and Gareis [25] with 15% trichloroacetic acid 
(0.2 mL) and dichloromethane (1 mL) by vigorous vortexing for 30 s in a 2 mL safe-lock 
polypropylene conical-bottom centrifuge tube. The mixture was allowed to stand for 24 h at room 
temperature, and then centrifuged at 14,000 × g for 10 min. The lower dichloromethane phase was 
carefully withdrawn by a Pasteur pipette and transferred to a 1.5 mL safe-lock polypropylene conical-
bottom centrifuge tube. The acidic phase and the compact precipitate layer formed between the two 
phases were re-extracted with dichloromethane (0.5 mL) for 30 s on a vortex mixer and then 
centrifuged for 5 min at 14,000 × g. The pooled dichloromethane extract was evaporated to dryness at 
40 °C under a gentle nitrogen flow. The remaining residue was dissolved in methanol (80 mL) and 
transferred to a 300 μL HPLC vial. The limit of detection (signal/noise: 3/1) was estimated at 0.1 ng 
OTA/mL, and recoveries was 95%. 
 
3.3.2. Extraction and clean-up for ochratoxin analyses from kidney and liver 
 
Kidney and liver analyses were performed by the method of Matrella et al. [69], which briefly 
includes a double extraction with acidic ethyl acetate. The organic phase was removed and extracted 
with 0.5M NaHCO3, pH 8.4. The aqueous extract was acidified to pH-2.5 with 7M H3PO4 OTA was 
finally back extracted into ethyl acetate (3 mL). The organic phase was evaporated to dryness under N2 
steam, reconstituted in 150 μL mobile phase and a 20 μL aliquot injected. The detection limit for OTA Int. J. Mol. Sci. 2008, 9          
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in organs was 0.01 ng/g with a 61% (C.V. =14.5%) mean recovery from artificially contaminated 
samples at 3 ng/g (n = 3). 
 
3.3.3. Chromatographic conditions (HPLC) 
 
An aliquot of 20 μL for serum samples and 50 μL for kidneys and liver samples were injected onto 
a Waters Symmetry Shield RP (Reversed phase) 18, high pressure liquid chromatography column 
(length and inner diameter 150×4, 6 mm, particle size 5 µm) on a Waters Alliance HPLC system. The 
column was eluted with 4% acetic acid and acetonitrile (32:68 v/v) at 25 °C and a flow rate of 1 
mL/min. Measurements were performed by fluorescence detection at wavelengths of 334 nm 
(excitation) and 460 nm (emission) gains 10. A volume of 10 μL was injected for the standards and 20 
μL for the samples. For more accuracy, 40 μL was re-injected in the case of the samples with an 
amount of OTA near the detection limit.   
 
3.3.4. Confirmation of Ochratoxin A by liquid chromatography tandem mass spectrometric method 
(LC-MS/MS) 
  
Analyses of serum, kidneys and liver sample were performed by the methods described above [19, 
52]. Sample extracts were evaporated to dryness under a gentle stream of nitrogen and stored at -18 °C 
prior to analysis.   
 
3.3.5. Liquid chromatography tandem mass spectrometric conditions 
 
Mass spectrometry was performed by Micromass Quattro II triple quadrupole mass spectrometer 
and MassLynx software for control and data processing. Electro spray ionization in the positive mode 
was used. The electro spray capillary was set at 3.2 kV and the cone at 30 V. The ion source 
temperature was set at 115 °C and the flow rates for nitrogen bath and spray were 700 l/h and 55 l/h, 
respectively. Data were acquired in the multiple reaction monitoring (MRM) modes. The collision 
energy was 18 eV. The transitions reactions monitored by LC-MS/MS were m/z 404→239 and m/z 
404→358 daughter ion of the ochratoxin A.   
 
3.4. Statistical analysis 
 
Descriptive statistics of the data set were performed with a standard programmed and included 
arithmetic mean, standard deviation, coefficient of variation, minimum, maximum. Statistical 
differences in the mean levels of OTA contamination across the three groups of positive samples were 
determined by one-way ANOVA (p<0.05). Significance was set at p<0.05. 
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